Ελληνικά
×
Pharmaceutical Services
Directors's Message
Mission and Responsibilities
Organisation Chart
Annual Report
Sectors
Regulatory
Marketing Authorisations for Medicinal Products
Post-approval procedures
Withdrawals
Submission/Validation of applications
Search for Medicinal Products for Human Use
Pharmacovigilance and Clinical Trials
Pharmacovigilance
Clinical Trials
Yellow Carrd
GMDP Inspectorate
Manufacture/Import from third countries Licence
Wholesale Licence
Medicinal Product Brokerage
Qualified Persons
Pharmacovigilance Inspections
Safety Features
Medicinal Products Pricing
Pricing Policy
Price List of Medicinal Products
Co-payment scheme for medicinal products
Price List Updates
Pharmacy Inspections - Pharmacist Registration
Pharmacies
Pharmacists
Annual Leave Pharmacies - Pharmacists
Narcotics, Psychotropics and Drug Precursors
Narcotics and Psychotropics
Drug Precursors
Cosmetics
Manufacturing Licences
Import of cosmetics
Labelling of cosmetics
Product Information File for Cosmetics
Cosmetics Notifications (CPNP)
Administration
Councils - Cyprus and EU Committees
Councils - Committees Cyprus
Participations in European and Other Committees
Legislation
European Regulations - Directives
Laws - Regulatory Administrative Acts
Circulars - Guidelines
Latest News
Cross-border prescriptions
Press releases
Events - Activities
Publications
Job Opportunities
Applications
Fees
Announcements
Media Gallery
COVID-19
CY RMS
Yellow Card
Recalls of Medicinal Products
On-Call Pharmacies
Announcements
Press Release
Applications
Fees
e-services / Drug Search
ΚΟΕΦ (CyMVO)
Price List of Medicinal Products
JCC payment
Office of Medicinal Cannabis
Online Pharmacy - Logo
Councils - Committees Cyprus
Cross-border prescriptions
News
- 29/06/2022
Possible use of the vaccine Jynneos against infection by monkeypox virus
- 29/06/2022
EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17
- 29/06/2022
EMA recommends Valneva’s COVID-19 vaccine for authorisation in the EU
- 29/06/2022
Monkeypox: EMA starts review for Imvanex
- 20/06/2022
Start of rolling review for adapted Spikevax COVID-19 vaccine
- 16/06/2022
Start of rolling review for adapted Comirnaty COVID-19 vaccine
- 05/04/2022
EMA starts rolling review of COVID-19 Vaccine HIPRA (PHH-1V)
- 28/03/2022
EMA recommends authorisation of COVID-19 medicine Evusheld
- 28/02/2022
EMA recommends authorisation of booster doses of Comirnaty from 12 years of age
- 28/02/2022
EMA recommends approval of Spikevax for children aged 6 to 11